Yi Wang

机构：Xiamen University · ORCID：0000-0001-8133-4413

发表论文 46 篇 · 总被引 701 次 · h-index 13

代表论文

• Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma (2022 · Cellular and Molecular Gastroenterology and Hepatology · 被引 53)
• m6A Reader Igf2bp1 Regulates the Inflammatory Responses of Microglia by Stabilizing Gbp11 and Cp mRNAs (2022 · Frontiers in Immunology · 被引 38)
• Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis (2023 · Journal of Translational Medicine · 被引 36)
• Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer (2022 · BMC Cancer · 被引 23)
• Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma (2021 · Cancer Management and Research · 被引 21)
• Inhibition of ribosomal RNA processing 15 Homolog (RRP15), which is overexpressed in hepatocellular carcinoma, suppresses tumour growth via induction of senescence and apoptosis (2021 · Cancer Letters · 被引 17)